A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer. Issue 2 (2021)

Record Type:: Journal Article
Title:: A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer. Issue 2 (2021)
Main Title:: A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer
Authors:: Johnson, Kai CC
Wesolowski, Robert
Gatti-Mays, Margaret E
Is Part Of:: Touch reviews in oncology & haematology. Volume 17:Issue 2(2021)
Journal:: Touch reviews in oncology & haematology
Issue:: Volume 17:Issue 2(2021)
Issue Display:: Volume 17, Issue 2 (2021)
Year:: 2021
Volume:: 17
Issue:: 2
Issue Sort Value:: 2021-0017-0002-0000
Page Start:
Page End:
Publication Date:: 2021
Subjects:: Oncology -- Periodicals
Hematology -- Periodicals
616.994005
Journal URLs:: https://touchoncology.com/journals/oncology-hematology-review-us/touchreviews-in-oncology-haematology-volume-17-issue-1-2021/ ↗
DOI:: ↗
Languages:: English
ISSNs:: 2752-5481
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 20269.xml